CMA1 and hypersensitivity pneumonitis: A decrease of apolipoprotein A‐I (apoA‐I) was associated with the pathogenesis of chronic hypersensitivity pneumonitis (HP) in terms of pulmonary fibrosis and mast cell chymase attenuated the protective effect of apoA‐I against pulmonary fibrosis.